Sickle Cell Disorders and Severe COVID-19 Outcomes: A Cohort Study
(2021)
Journal Article
Clift, A. K., Saatci, D., Coupland, C. A., Dambha-Miller, H., Hippisley-Cox, J., & International Investigator Group for Ethnicity and COVID-19. (2021). Sickle Cell Disorders and Severe COVID-19 Outcomes: A Cohort Study. Annals of Internal Medicine, 174(10), 1483-1487. https://doi.org/10.7326/M21-1375
Background: Sickle cell disease is a collection of compound heterozygote hemoglobinopathies, including sickle cell anemia (1). The heterozygote hemoglobinopathies are characterized by erythrocyte deformation with hemolysis; immune and coagulation dys... Read More about Sickle Cell Disorders and Severe COVID-19 Outcomes: A Cohort Study.